View Older Stories View More Recent Stories

May 4, 2022 04:02PM Novavax to Participate in BofA Securities 2022 Healthcare Conference
May 2, 2022 04:02PM Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Operational Highlights on May 9, 2022
Apr 8, 2022 09:00AM Novavax (NVAX), Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand
Apr 8, 2022 09:00AM Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand
Mar 31, 2022 06:04AM Novavax (NVAX) Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the EU to Adolescents (Ages 12-17)
Mar 31, 2022 06:00AM Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)
Mar 25, 2022 08:30AM Novavax (NVAX) Announces Participation in Two Booster Studies Using its COVID-19 Vaccine
Mar 25, 2022 08:30AM Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine
Mar 22, 2022 04:03PM Novavax (NVAX), Serum Institute of India Announce EUA for COVID-19 Vaccine
Mar 22, 2022 04:02PM Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India
Mar 10, 2022 09:01AM Novavax (NVAX) Launches Global Vaccine Education Programs
Mar 10, 2022 09:00AM Novavax Announces Launch of Global Vaccine Education Programs
Mar 2, 2022 04:02PM Novavax to Participate in Cowen's 42nd Annual Health Care Conference
Feb 28, 2022 04:02PM Novavax Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Feb 21, 2022 04:01PM Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 28, 2022
Feb 10, 2022 04:02PM Novavax (NVAX) Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Feb 10, 2022 04:02PM Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Jan 20, 2022 05:38AM Novavax (NVAX) Granted Provisional Registration for COVID-19 Vaccine in Australia
Jan 19, 2022 06:21PM Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Jan 12, 2022 06:00AM Novavax (NVAX) COVID-19 Vaccine Approved in South Korea
Jan 12, 2022 06:00AM South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine
Jan 10, 2022 08:40AM Novavax (NVAX) and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa
Jan 10, 2022 08:39AM Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax' COVID-19 Vaccine in South Africa
Jan 4, 2022 04:02PM Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Dec 31, 2021 12:15PM Novavax (NVAX) Submits Final Data Packages to U.S. FDA for COVID-19 Vaccine EUA Authorization
Dec 31, 2021 12:15PM Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine
Dec 28, 2021 09:29AM Novavax (NVAX) and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India
Dec 28, 2021 09:29AM Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India
Dec 27, 2021 05:38AM Novavax (NVAX) and SK bioscience Announce Expansion of Manufacturing Agreement
Dec 23, 2021 06:30PM Novavax and SK bioscience Expand Manufacturing Agreement
Dec 22, 2021 04:02PM Novavax (NVAX) Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies
Dec 22, 2021 04:02PM Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies
Dec 21, 2021 05:01PM Novavax (NVAX) Initiates PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study
Dec 21, 2021 05:01PM Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study
Dec 21, 2021 04:45PM WHO SAGE Issues Interim Recommendations for Novavax (NVAX) COVID-19 Vaccine
Dec 21, 2021 04:44PM World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine
Dec 20, 2021 12:20PM WHO Grants Second Emergency Use Listing for Novavax (NVAX) COVID-19 Vaccine
Dec 20, 2021 12:19PM World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine
Dec 20, 2021 11:00AM Novavax (NVAX) COVID-19 Vaccine Granted Conditional Marketing Authorization in Europe
Dec 20, 2021 10:59AM European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
Dec 20, 2021 08:26AM Novavax (NVAX) Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine
Dec 20, 2021 08:25AM Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine
Dec 17, 2021 10:41AM Novavax (NVAX), Serum Institute of India Confirm WHO Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine
Dec 17, 2021 10:37AM Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine
Dec 16, 2021 06:06AM Novavax (NVAX) Submits New Drug Application in Japan for Approval of COVID-19 Vaccine
Dec 15, 2021 11:02PM Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Dec 13, 2021 06:30AM Novavax (NVAX) Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates
Dec 13, 2021 06:30AM Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates
Nov 24, 2021 08:30AM Novavax (NVAX) Files for Interim Authorization of its COVID-19 Vaccine in Singapore
Nov 24, 2021 08:30AM Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore
View More Recent Stories View Older Stories